Login / Signup
Igor N Sychev
(I N Sychev, Igor Sychev)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 5
Top Topics
Venous Thromboembolism
Primary Care
Replacement Therapy
Methicillin Resistant Staphylococcus Aureus
Top Venues
Terapevticheskii arkhiv
Drug metabolism and personalized therapy
Pharmacogenomics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Svetlana Rachina
,
Ludmila Fedina
,
Marina V Sukhorukova
,
Igor N Sychev
,
E S Larin
,
A Alkhlavov
[Diagnosis and antibiotic therapy of nosocomial pneumonia in adults: from recommendations to real practice. A review].
Terapevticheskii arkhiv
95 (11) (2023)
Svetlana Rachina
,
Ludmila Fedina
,
Marina V Sukhorukova
,
Igor N Sychev
,
E S Larin
,
A Alkhlavov
[Diagnosis and antibiotic therapy of nosocomial pneumonia in adults: from recommendations to real practice. A review].
Terapevticheskii arkhiv
95 (11) (2023)
Dmitry Alekseevich Sychev
,
Ludmila Fedina
,
Maria Poptsova
,
Dmitry A Zateyshchikov
,
Karin Badavievich Mirzaev
,
Evgeny Tsimbal
,
Igor N Sychev
,
Tatiana Rastvorova
A survey of physician opinions in Russia in the field of pharmacogenetics of cardiovascular disease.
Pharmacogenomics
23 (15) (2022)
Eric Rytkin
,
Irina Vladimirovna Bure
,
Pavel O Bochkov
,
Kristina Anatolyevna Akmalova
,
Karin Badavievich Mirzaev
,
Marina S Cherniaeva
,
Olga Dmitrievna Ostroumova
,
Valeriy V Smirnov
,
Elena A Grishina
,
Anna G Saribekian
,
Igor N Sychev
,
Dmitry Alekseevich Sychev
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Drug metabolism and personalized therapy
37 (1) (2021)
Eric Rytkin
,
Irina Vladimirovna Bure
,
Pavel O Bochkov
,
Kristina Anatolyevna Akmalova
,
Karin Badavievich Mirzaev
,
Marina S Cherniaeva
,
Olga Dmitrievna Ostroumova
,
Valeriy V Smirnov
,
Elena A Grishina
,
Anna G Saribekian
,
Igor N Sychev
,
Dmitry Alekseevich Sychev
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Drug metabolism and personalized therapy
(2021)